VP Commercialization Strategies, XIFIN, Inc.
Rina Wolf is a nationally recognized expert in the field of laboratory commercialization and reimbursement, with over 20 years of experience in the diagnostic laboratory industry, specializing in Molecular Diagnostic Laboratories. Currently, Rina is the Vice President of Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc. She lectures extensively on these topics and has consulted for over 50 laboratories in the areas of commercialization, optimizing reimbursement and coverage, and compliance. Prior to joining XIFIN, Rina was responsible for creating and implementing successful reimbursement strategies with executive positions in the area of commercialization and reimbursement.
Session: Reimbursement Challenges and Solutions for Molecular Diagnostic
Research continues to confirm that adoption of personalized diagnostics is limited by physicians’ lack of confidence in when and how to utilize these tests and their results. Significant challenges remain around appropriately incorporating molecular diagnostics into the clinic so they are used effectively and are reimbursable. In this session you will hear the perspectives of both public and private payers, healthcare providers, and patients as well as about a new resource that may be able to fill an unmet need in this space.